Showing results (31-40 of 104) with videos related to
Sort By:
Pageof 11
The Indian Journal of Chest Diseases & Allied Sciences|March 31, 2011
Immune responses to mycobacterial antigens in sarcoidosis: a systematic reviewD Gupta, R Agarwal, A N Aggarwal, et al.Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|October 29, 2013
Effect of IL-12B, IL-2, TGF-β1, and IL-4 polymorphism and expression on hepatitis B progressionRoli Saxena, Yogesh Kumar Chawla, Indu Verma, et al.Applied Microbiology and Biotechnology|September 1, 2017
Activity of human beta defensin-1 and its motif against active and dormant Mycobacterium tuberculosisRicha Sharma, Uma Nahar Saikia, Sadhna Sharma, et al.Indian Journal of Pathology & Microbiology|November 4, 2010
Nonspecificity of 35 kDa protein: a proposed marker for the differential diagnosis of M. avium infection in the Indian populationKapil Gupta, Rajiv Mahajan, Gopal K Khuller, et al.Indian Journal of Community Medicine : Official Publication of Indian Association of Preventive & Social Medicine|January 24, 2022
Perinatal Outcome in Pregnancies Associated with Hypertension: A Prospective Cohort Study in a Rural Tertiary Care Teaching Hospital of North IndiaIndu Verma, Charvi Chugh, Dinesh Sood, et al.American Journal of Human Biology : the Official Journal of the Human Biology Council|May 21, 2014
IL-6(-572/-597) polymorphism and expression in HBV disease chronicity in an Indian populationRoli Saxena, Yogesh Kumar Chawla, Indu Verma, et al.Journal of Global Infectious Diseases|September 3, 2011
Evaluation of Aro-Tal-AST Complex Protein as a Marker for Differential Diagnosis of Mycobacterium Avium InfectionKapil Gupta, Indu Verma, Gopal K Khuller, et al.Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|December 6, 2012
Interleukin-1 polymorphism and expression in hepatitis B virus-mediated disease outcome in IndiaRoli Saxena, Yogesh Kumar Chawla, Indu Verma, et al.Vaccine|July 5, 2005
Immunodominance of low molecular weight secretory polypeptides of Mycobacterium tuberculosis to induce cytotoxic T-lymphocyte responseSuraj B Sable, Sukhwinder Kaur, Indu Verma, et al.Clinical Immunology (Orlando, Fla.)|January 9, 2007
Tuberculosis subunit vaccine design: the conflict of antigenicity and immunogenicitySuraj B Sable, Mamta Kalra, Indu Verma, et al.Pageof 11